AVGR - Avinger, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.4580
-0.0117 (-2.49%)
At close: 4:00PM EDT

0.4600 0.00 (0.44%)
After hours: 5:46PM EDT

Stock chart is not supported by your current browser
Previous Close0.4697
Open0.4800
Bid0.4400 x 1100
Ask0.4795 x 800
Day's Range0.4401 - 0.4899
52 Week Range0.1800 - 2.0300
Volume724,561
Avg. Volume4,356,612
Market Cap29.402M
Beta (3Y Monthly)3.09
PE Ratio (TTM)N/A
EPS (TTM)-1.2370
Earnings DateMay 2, 2018 - May 7, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.50
Trade prices are not sourced from all markets
  • ACCESSWIRE15 days ago

    Avinger Announces Distribution Agreement for Hong Kong

    REDWOOD CITY, CA / ACCESSWIRE / June 4, 2019 / Avinger, Inc. (AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced it has entered into an exclusive distribution agreement with Integmed Ltd. for the sales and marketing of Avinger's Lumivascular products in Hong Kong. Initial product shipments are anticipated during the current quarter and first patient treatments in Hong Kong are expected to commence in the third quarter of 2019. Integmed is a leading distributor of medical devices in Hong Kong for the treatment of cardiovascular disease, including a portfolio of complementary products for the endovascular treatment of arterial disease.

  • ACCESSWIRE20 days ago

    Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference

    REDWOOD CITY, CA / ACCESSWIRE / May 30, 2019 / Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...

  • Is Avinger (AVGR) Stock Outpacing Its Medical Peers This Year?
    Zacks26 days ago

    Is Avinger (AVGR) Stock Outpacing Its Medical Peers This Year?

    Is (AVGR) Outperforming Other Medical Stocks This Year?

  • ACCESSWIRElast month

    Avinger Announces Successful Treatment of 1,000th Patient with Next-Generation Pantheris Device

    REDWOOD CITY, CA / ACCESSWIRE / May 16, 2019 / Avinger, Inc. (AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that physicians in 78 clinical sites have successfully treated more than 1,000 patients with the next-generation Pantheris image-guided atherectomy system. The next-generation Pantheris was launched on a limited basis in the U.S. following receipt of 510(k) clearance by the U.S. Food and Drug Administration (FDA) in late May 2018 and features a number of improvements intended to augment the performance and reliability of the product. Importantly, clinical results have remained consistently positive in a variety of lesion types since market launch.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of AVGR earnings conference call or presentation 8-May-19 8:30pm GMT

    Q1 2019 Avinger Inc Earnings Call

  • Associated Presslast month

    Avinger: 1Q Earnings Snapshot

    The Redwood City, California-based company said it had a loss of 14 cents per share. The medical device maker posted revenue of $1.8 million in the period. In the final minutes of trading on Wednesday, ...

  • GlobeNewswirelast month

    Avinger Provides First Quarter 2019 Shareholder Update

    REDWOOD CITY, Calif., May 08, 2019 -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,.

  • ACCESSWIRElast month

    Avinger, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 8, 2019 / Avinger, Inc. (NASDAQ: AVGR ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 8, 2019 at 4:30 PM Eastern Time. ...

  • Is Avinger (AVGR) Outperforming Other Medical Stocks This Year?
    Zacks2 months ago

    Is Avinger (AVGR) Outperforming Other Medical Stocks This Year?

    Is (AVGR) Outperforming Other Medical Stocks This Year?

  • Avinger (AVGR) Dips More Than Broader Markets: What You Should Know
    Zacks2 months ago

    Avinger (AVGR) Dips More Than Broader Markets: What You Should Know

    Avinger (AVGR) closed at $0.58 in the latest trading session, marking a -0.62% move from the prior day.

  • ACCESSWIRE2 months ago

    Avinger to Announce First Quarter 2019 Financial Results on May 8, 2019

    REDWOOD CITY, CA / ACCESSWIRE / May 2, 2019 / Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...

  • ACCESSWIRE2 months ago

    Avinger Announces Issuance of New U.S. Patent and Receives Notice of Allowance for Five Additional U.S. Patents

    Extensive Intellectual Property Portfolio Now Includes 149 Patents and Applications REDWOOD CITY, CA / ACCESSWIRE / April 17, 2019 / Avinger, Inc. (NASDAQ: AVGR ), a leading developer of image-guided, ...

  • ACCESSWIRE2 months ago

    Avinger Announces Publication of Study Demonstrating Positive Clinical Outcomes for Patients Treated with Pantheris Prior to Antirestenotic Therapy

    REDWOOD CITY, CA / ACCESSWIRE / April 15, 2019 / Avinger, Inc. (NASDAQ: AVGR), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced the publication of very promising clinical outcomes data from a study evaluating the performance of the Pantheris® Lumivascular atherectomy system combined with antirestenotic therapy in the treatment of PAD. The study analyzed the clinical outcomes of 33 patients (37 lesions) with symptomatic peripheral arterial disease treated by OCT-guided atherectomy with Pantheris prior to application of a drug-coated balloon.

  • Top Ranked Momentum Stocks to Buy for April 11th
    Zacks2 months ago

    Top Ranked Momentum Stocks to Buy for April 11th

    Top Ranked Momentum Stocks to Buy for April 11th

  • EDAP TMS (EDAP) Looks Good: Stock Adds 7.9% in Session
    Zacks2 months ago

    EDAP TMS (EDAP) Looks Good: Stock Adds 7.9% in Session

    EDAP TMS (EDAP) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

  • GlobeNewswire2 months ago

    Avinger Receives FDA Clearance of Pantheris SV Device

    Avinger, Inc. (AVGR), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that the Company received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pantheris SV (Small Vessel) image-guided atherectomy system. Pantheris SV, a product line extension of Avinger’s Lumivascular image-guided atherectomy platform, is expected to expand the available market for Pantheris by up to 50% and allow the Company to address a larger portion of the estimated $500 million atherectomy market.

  • Top Ranked Momentum Stocks to Buy for April 9th
    Zacks2 months ago

    Top Ranked Momentum Stocks to Buy for April 9th

    Top Ranked Momentum Stocks to Buy for April 9th

  • ACCESSWIRE3 months ago

    Avinger Receives $6.2 Million from Warrant Exercises

    REDWOOD CITY, CA / ACCESSWIRE / March 27, 2019 / Avinger, Inc. (NASDAQ: AVGR ), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery ...

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of AVGR earnings conference call or presentation 6-Mar-19 9:30pm GMT

    Q4 2018 Avinger Inc Earnings Call

  • GlobeNewswire3 months ago

    Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update

    REDWOOD CITY, Calif., March 06, 2019 -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,.

  • Benzinga3 months ago

    Avinger's Q4 Earnings Outlook

    On Wednesday, Mar. 6, Avinger (NASDAQ: AVGR ) will release its latest earnings report. Decipher the announcement with Benzinga's help. Earnings and Revenue Analysts are predicting Avinger will report a ...

  • ACCESSWIRE4 months ago

    Avinger to Present at Oppenheimer Healthcare Conference on March 20

    REDWOOD CITY, CA / ACCESSWIRE / March 1, 2019 / Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced today announced that Jeff ...

  • GlobeNewswire4 months ago

    Avinger to Announce Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019

    Avinger, Inc. (AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that it will release its financial results for the fourth quarter and full year 2018 after the close of trading on Wednesday, March 6, 2019. Individuals interested in listening to the conference call may do so by dialing 877-407-9205 for domestic callers or +1-201-689-8054 for international callers. To listen to a live webcast, please visit http://www.avinger.com and select Investor Relations.

  • GlobeNewswire5 months ago

    Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019

    Avinger, Inc. (AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Pantheris® SV (Small Vessel) image-guided atherectomy system was featured in a live case transmission at Leipzig Interventional Course (LINC) 2019, a leading global forum for new methods and technology in the field of vascular medicine held annually in Leipzig, Germany. Pantheris SV is a product line extension of Avinger’s Lumivascular image-guided atherectomy system. Designed with a lower profile and longer length, Pantheris SV is intended to expand the addressable market for Pantheris, by allowing physicians to treat lesions in smaller vessels 2 to 4 millimeters in diameter.

  • Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger
    Zacks5 months ago

    Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger

    Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger